Last reviewed · How we verify

NCT04617808: CEPHAREG

Predictive Score for Non-traumatic Secondary Headache After an Emergency Call

Completed Last updated 28 March 2022
What this trial tests

trial testing Questionnaire in Headache in 715 participants. Completed in 31 May 2021.

Timeline
21 October 2020
Primary endpoint
31 May 2021
31 May 2021

Quick facts

Lead sponsorCentre Hospitalier Régional d'Orléans
StatusCompleted
Study typeOBSERVATIONAL
Enrollment715
Start date21 October 2020
Primary completion31 May 2021
Estimated completion31 May 2021
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Régional d'Orléans

Who can join

18 and older, any sex, with Headache or Emergencies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study objective was to identify predictive criteria of severe non-traumatic secondary headache among the information gathered during telephone interview conducted by the on-call regulating physician at the Centre15.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Headache

Currently open trials in the same condition.

Other Centre Hospitalier Régional d'Orléans trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04617808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing